# NEXGEL, Inc. (NXGL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NXGL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 11.69M | $ -3.07M | $ -1.34M | $ 3.09M | $ 4.46M |
| 2024 | $ 9.13M | $ -3.45M | $ -4.53M | $ 2.83M | $ 5.76M |
| 2023 | $ 4.42M | $ -3.41M | $ -4.25M | $ 2.80M | $ 4.70M |
| 2022 | $ 2.29M | $ -5.30M | $ -3.45M | $ 2.08M | $ 7.64M |
| 2021 | $ 1.84M | $ -5.12M | $ -3.59M | $ 4.26M | $ 12.09M |
| 2020 | $ 858.6K | $ -2.88M | $ -2.69M | $ 1.28M | $ 71.0K |
| 2019 | $ 925.5K | $ -2.48M | $ -2.34M | $ 917.0K | $ 380.0K |
| 2018 | $ 2.92M | $ -2.61M | $ -2.04M | $ 0 | $ 281.0K |
| 2017 | $ 891.8K | $ -261.3K | $ 94.3K | $ 0 | $ 625.0K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.69 |
| Liabilities / Eq | 1.25 |
| Current Ratio | 1.47 |

## Other views

- [Metrics](https://sponda.capital/en/NXGL.md)
- [Charts](https://sponda.capital/en/NXGL/charts.md)
- [Compare](https://sponda.capital/en/NXGL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.